US FDA declines to approve Fortress Bio and Zydus' treatment for a rare pediatric disease

Fortress Biotech on Wednesday said the U.S. Food and Drug Administration declined to approve the drug it is developing with ...
cnbctv18

Unichem Laboratories' US arm voluntarily recalls one lot of mislabelled Cyclobenzaprine Hydrochloride tablets

Unichem Laboratories Ltd. on Wednesday, September 3, said its wholly-owned subsidiary Unichem Pharmaceuticals (USA) Inc. has issued a voluntary nationwide recall of the Cyclobenzaprine Hydrochloride ...
Monthly Prescribing Reference

Meloxicam Tablets Mislabeled as Cyclobenzaprine HCl Prompt Recall

The recall involves Lot# GMML24026A (NDC# 29300-415-19) with an expiration date of September 2027. Unichem Pharmaceuticals is recalling 1 lot of Cyclobenzaprine Hydrochloride Tablets USP, 10mg due to ...
GSM Arena

Samsung Galaxy Tab S10 Lite new color and full specs surface online

Samsung’s Galaxy Tab S10 Lite is expected to launch later this year alongside the Galaxy Tab S11 and Tab S11 Ultra. Recently, images of the Tab S10 Lite in gray and pinkish color options had leaked.
Medscape

FDA Approves First-in-Class Drug for Fibromyalgia

The FDA has approved cyclobenzaprine hydrochloride sublingual tablets (Tonmya, Tonix Pharmaceuticals), a first-in-class, nonopioid treatment for adults with fibromyalgia, a chronic pain syndrome that ...
Taiwan News

Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia

CHATHAM, N.J., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company, today announced that the U.S. Food and Drug ...